or Try an Advanced Search...

    Treatment Of Cardiovascular Disease Stocks List

    Symbol Grade Name % Change
    XENE D Xenon Pharmaceuticals Inc. 2.70
    CDIO F Cardio Diagnostics Holdings Inc. 0.33
    GILD F Gilead Sciences, Inc. 0.12
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Cardiovascular Disease Biopharmaceutical Acne Alipogene Tiparvovec Analgesics Angina Antibiotics Artificial Intelligence Biotechnology Chemical Compounds Coronavirus Cystic Fibrosis Cytomegalovirus Retinitis Disease Epigenetics Erythromelalgia Fungal Infection Fungal Infections Gene Therapy Gilead Sciences

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Cardiovascular Disease stocks.

    Symbol Grade Name Weight
    IBB D iShares Nasdaq Biotechnology Index Fund 8.48
    IBBQ C Invesco Nasdaq Biotechnology ETF 8.47
    BBH D Market Vectors Biotech ETF 7.99
    BIS B ProShares UltraShort Nasdaq Biotechnology 7.41
    PBE D PowerShares Dynamic Biotech & Genome 7.4
    View all Treatment Of Cardiovascular Disease ETFs...
    Compare ETFs
    Compare BBH to BIS Compare IBB to BIS Compare IBBQ to PBE

        Treatment Of Cardiovascular Disease Stocks Recent News

        Date Stock Title
        Apr 23 GILD Incyte (INCY) Earnings Expected to Grow: Should You Buy?
        Apr 23 GILD Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern?
        Apr 22 GILD Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
        Apr 22 GILD Gilead Sciences: Some Signs Of An Impending Bottom
        Apr 22 GILD Insights Into Gilead (GILD) Q1: Wall Street Projections for Key Metrics
        Apr 21 GILD Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
        Apr 19 GILD FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk
        Apr 18 GILD US FDA mandates label updates on CAR-T cancer therapies
        Apr 18 GILD Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
        Apr 18 GILD Gilead Sciences Publishes 2023 ESG Impact Report
        Apr 18 GILD Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
        Apr 17 GILD GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Cardiovascular Disease Biopharmaceutical Acne Alipogene Tiparvovec Analgesics Angina Antibiotics Artificial Intelligence Biotechnology Chemical Compounds Coronavirus Cystic Fibrosis Cytomegalovirus Retinitis Disease Epigenetics Erythromelalgia Fungal Infection Fungal Infections Gene Therapy Gilead Sciences
        Treatment Of Cardiovascular Disease

        Treatment of cardiovascular disease typically involves lifestyle changes, such as quitting smoking, exercising regularly, and eating a healthy diet. Medications, such as statins, ACE inhibitors, and beta-blockers, may also be prescribed to reduce the risk of heart attack and stroke. In some cases, surgery may be necessary to repair or replace damaged heart valves or arteries.

        Browse All Tags